NQMC Update Service: July 18, 2016 || Health Resources and Services Administration

NQMC Update Service: July 18, 2016

Health Resources and Services Administration

• AIDS Drug Assistance Program (ADAP): percentage of ADAP applications approved or denied for new ADAP enrollment within 14 days (two weeks) of ADAP receiving a complete application in the measurement year.
• AIDS Drug Assistance Program (ADAP): percentage of ADAP enrollees who are reviewed for continued ADAP eligibility two or more times in the measurement year.
• AIDS Drug Assistance Program (ADAP): percentage of identified inappropriate antiretroviral (ARV) regimen components prescriptions that are resolved by the ADAP program during the measurement year.
• AIDS Drug Assistance Program (ADAP): percentage of new anti-retroviral classes that are included in the ADAP formulary within 90 days of the date of inclusion of new anti-retroviral classes in the U.S. Public Health Service (PHS) Guidelines for the Use of Antiretroviral Agents in HIV-1-infected Adults and Adolescents during the measurement year.
• HIV diagnostic testing: percentage of exposed infants born to HIV-infected women who received recommended virologic diagnostic testing for exclusion of HIV infection in the measurement year.
• HIV oral health services: percentage of HIV-infected oral health patients who had a dental and medical health history (initial or updated) at least once in the measurement year.
• HIV oral health services: percentage of HIV-infected oral health patients who had a dental treatment plan developed and/or updated at least once in the measurement year.
• HIV oral health services: percentage of HIV-infected oral health patients who had a periodontal screen or examination at least once in the measurement year.
• HIV oral health services: percentage of HIV-infected oral health patients who received oral health education at least once in the measurement year.
• HIV oral health services: percentage of HIV-infected oral health patients with a Phase 1 treatment plan that is completed within 12 months.
• Measles, mumps, and rubella (MMR) vaccine: percentage of pediatric patients with HIV infection who have had at least one dose of MMR vaccine administered between 12 to 24 months of age.
• Neonatal zidovudine (ZDV) prophylaxis: percentage of infants born to HIV-infected women who were prescribed ZDV prophylaxis for HIV within 12 hours of birth during the measurement year.
• Pneumocystis carinii pneumonia (PCP) prophylaxis: percentage of eligible infants with HIV-exposure who were prescribed PCP prophylaxis in the measurement year.